American Medical Association Leading Charge for CLIA Modernization

The American Medical Association is leading a lobbying effort to get the Senate health committee to modernize the Clinical Laboratory Improvement Amendments program under a framework giving CLIA oversight of most high-complexity tests, while giving FDA authority over high-risk tests that have a large potential for misuse as well as those for which third-party accreditors can't effectively determine analytical and clinical validity, according to industry sources and an AMA discussion document obtained by Inside Health Policy . The AMA...